Quarter Period Statement Of Income

ONO PHARMACEUTICAL CO., LTD. - Filing #7330506

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Quarter period statement of income
Statement of income
Net sales
498,777,000,000 JPY
441,242,000,000 JPY
Cost of sales
109,585,000,000 JPY
102,363,000,000 JPY
Gross profit (loss)
389,192,000,000 JPY
338,880,000,000 JPY
Selling, general and administrative expenses
201,276,000,000 JPY
186,876,000,000 JPY
Selling, general and administrative expenses
Salaries
12,538,000,000 JPY
12,497,000,000 JPY
Depreciation
966,000,000 JPY
712,000,000 JPY
Operating profit (loss)
187,916,000,000 JPY
152,004,000,000 JPY
Non-operating income
Interest income
1,101,000,000 JPY
68,000,000 JPY
Dividend income
2,445,000,000 JPY
2,334,000,000 JPY
Non-operating income
5,279,000,000 JPY
3,259,000,000 JPY
Non-operating expenses
Interest expenses
30,000,000 JPY
32,000,000 JPY
Non-operating expenses
5,159,000,000 JPY
4,507,000,000 JPY
Ordinary profit (loss)
188,036,000,000 JPY
150,755,000,000 JPY
Extraordinary income
Extraordinary income
12,403,000,000 JPY
4,769,000,000 JPY
Extraordinary losses
Extraordinary losses
2,400,000,000 JPY
7,344,000,000 JPY
Profit (loss) before income taxes
198,039,000,000 JPY
148,181,000,000 JPY
Income taxes - current
41,265,000,000 JPY
39,820,000,000 JPY
Income taxes - deferred
3,865,000,000 JPY
-8,829,000,000 JPY
Income taxes
45,130,000,000 JPY
30,991,000,000 JPY
Profit (loss)
152,909,000,000 JPY
152,909,000,000 JPY
152,909,000,000 JPY
152,909,000,000 JPY
117,190,000,000 JPY
117,190,000,000 JPY
117,190,000,000 JPY
117,190,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.